AffiliationDepartment of Radiotherapy-Related Research, The Christie NHS Foundation Trust, Manchester, UK. Caroline.Henson@christie.nhs.uk
MetadataShow full item record
AbstractTo review the evidence for candidate biomarkers of gastrointestinal toxicity following pelvic radiotherapy to highlight recent findings of potential interest to those involved in the treatment of pelvic malignancies or the management of gastrointestinal consequences of cancer treatments.
CitationBiomarkers of normal tissue toxicity after pelvic radiotherapy. 2012, 6 (1):33-40 Curr Opin Support Palliat Care
JournalCurrent Opinion in Supportive and Palliative Care
- Nurse-led care for the management of side effects of pelvic radiotherapy: what does it achieve?
- Authors: Dunberger G, Bergmark K
- Issue date: 2012 Mar
- Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy.
- Authors: Varela E, Antolín M, Guarner F, Verges R, Giralt J, Malagelada JR
- Issue date: 2009 Jul 1
- Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?
- Authors: Wedlake L, McGough C, Hackett C, Thomas K, Blake P, Harrington K, Tait D, Khoo V, Dearnaley D, Andreyev HJ
- Issue date: 2008 May
- Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients.
- Authors: Andreyev J
- Issue date: 2007 Nov
- Measurement tools for gastrointestinal symptoms in radiation oncology.
- Authors: West CM, Davidson SE
- Issue date: 2009 Mar